RecruitingNCT07015944
Depression support for breast cancer survivors in Pakistan
About this title
Read the official source — NCT07015944Medication studyAges 18+Pakistan
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- KarachiSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 13, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 26,376
- Sponsor
- Pakistan Institute of Living and Learning
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Not clearly listed
- Locations
- Pakistan
- Age range
- Over 18 Years
- Official registry ID
- NCT07015944
- Official title
Show the full official title
Clinical and Cost-effectiveness of an Integrated Psychosocial Care Plan for Comorbid Depression in Breast Cancer Survivors In Pakistan: A Sequential Multiple Assignment Randomised Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Karachi
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Pakistan Institute of Living and Learning, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Standardised pharmacological treatment (antidepressants).
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
